against both homologous and heterologous strains, and this protection was due to antibody production. An examination of the various phases of growth of K. pneumoniae showed that there was extracellular release of the component parts of the ETC occurring during all phases of growth. The presence of the ETC in the supernatant fluids was due to actual release of this material as opposed to cell lysis. Antibodies to the lipopolysaccharide portion (which has been shown to possess the observed toxicity) of the ETC were protective against the homologous bacterium.
The importance of Klebsiella species in the everincreasing number of gram-negative, aerobic bacillary nosocomial infections in the United States has been well documented (11, 15) . Pneumonias caused by Klebsiella species (most notably Klebsiella pneumoniae) are particularly difficult to control (12, 15) , and mortality rates can reach 50%, even after antibiotic therapy (11, 15) . Also, K. pneumoniae pneumonias differ from most other bacterial pneumonias in that lung destruction seen in this disease state is often extensive (13) .
We have shown that virulent strains of K. pneumoniae can produce a lobar pneumonia in normal animals that is characterized by extensive pulmonary tissue destruction (5) . We also showed that there is a correlation between the production of extracellular polysaccharides (both lipopolysaccharide [LPS] and capsular polysaccharide [CPS] ) and the virulence of the producing organism (4) . However, only purified extracellular LPS (ELPS) enhanced the virulence of K. pneumoniae when coinjected into mice, and this virulence enhancement correlated with the content of ELPS but not the extracellular CPS in mixtures of these polysaccharides (4) . Those studies, along with the work of Mizuta et al. (18) , led us to hypothesize that there might be an extracellular toxic substance produced by these organisms that is responsible for the observed lethality and extensive lung pathology. Mizuta et al. (18) suggested that there is something other than the cell-associated capsular material that plays a role in the virulence of K. pneumoniae. These workers found avirulent strains of the 01:K2 serogroup of K. pneumoniae that were fully encapsulated.
We recently described the production of an extracellular toxic complex (ETC) that appeared to be responsible for lethality and the extensive lung pathology produced by K. pneumoniae in animal models (27) . This ETC was made of 63% CPS, 30% LPS, and 7% protein. Saponification studies demonstrated that the toxicity of the ETC was associated with the LPS, but the LPS alone was decidedly less toxic than the entire complex. Since the ETC from only one strain of K. pneumoniae was employed in the above study, I decided to examine additional strains for the production of this compound.
MATERIALS AND METHODS Bacteria. The K. pneumoniae serotype 1 (KP1) strains included ATCC 8047 (a lung isolate from the American Type Culture Collection, Rockville, Md.) and CDC 2-70 (Centers for Disease Control, Atlanta, Ga.). The K. pneumoniae serotype 2 (KP2) strains included ATCC 29011 and CDC 2-70. The KP1 8047 and the KP2 29011 strains have two variants with respect to capsule size (5). These subtypes bred true and were referred to as large capsule (LC) and small capsule (SC) variants. The four variants utilized in these studies were therefore designated KP1-LC, KP1-SC, KP2-LC, and KP2-SC. All strains belonged to the 0 antigen serogroup 01.
All strains were stored at -70°C in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) with 20% glycerol. Serotype specificity was tested in capillary precipitin reactions against rabbit anticapsular antisera raised against Formalin-killed whole cells by the procedure of Edmondson and Cooke (6) . The capsule size, rat lung infectivity, and virulence in mice of these organisms have already been established (4) .
Media, growth conditions, purification, and quantitation of ETC from various K. pneumoniae strains and ELPS from KP2 2-70. Media, growth conditions, purification, and quantitation of ETC and ELPS were all as previously described (27) . The ELPS from KP2 2-70 was obtained by electrodialysis and gel filtration in the presence of 0.1% sodium dodecyl sulfate as previously described (27) .
The purified ETC and ELPS were assayed for protein by the procedure of Lowry et al. (16) nm (OD550) = 0.1 (lag phase), OD550 = 0.3 (early log phase), OD550 = 0.8 (late log phase), OD550 = 1.0 (early stationary phase), and OD550 = 1.2 (late stationary phase), immediately chilled on ice, and centrifuged at 17,700 x g for 30 min at 4°C. The supernatants were dialyzed with stirring at 4°C against 8 liters of deionized water for 3 days with daily changes and lyophilized. Samples were suspended in 5 ml of distilled water and assayed for CPS (1) , LPS (19) , and protein (16) . The quantity of CPS was calculated from the proportion of the polysaccharide structural repeat unit that is uronic acid for CPS from serotype 2 (26.43%) strains (20) . Ketodeoxyoctonate assays for LPS utilized E. coli O55:B5 LPS as the standard, and the LPS units were expressed in micrograms of E. coli LPS equivalents.
To determine the percent lysis of K. pneumoniae at various points in the growth curve, I used the following procedure. For each point in the growth curve, the amount of free DNA in the supernatant was calculated by the modified diphenylamine method described by Giles and Myers (10) with similarly hydrolyzed calf thymus DNA as a standard. To determine the amount of DNA in the cell pellets at each stage of growth, the cells were harvested by centrifugation and adjusted to a cell density of between 1 x 108 and 2 x 108 CFU/ml. Cell pellets were washed three times by centrifugation and suspended in 5 ml of ice-cold buffered saline containing 0.01% gelatin (usually at 109 cells per ml) with cell numbers being determined on a Coulter Counter. Concentrated perchloric acid was then added to a final concentration of 1.0 M, and the mixture was heated to 90°C for 20 min before stirring. The hydrolyzed samples were chilled in an ice bath and centrifuged to pellet the acid-insoluble cell components. The supernatant (acidsoluble cell contents) was assayed for DNA (10) . The DNA in the various 200-ml supernatants plus the DNA released from the various cell pellets represented the total DNA. The amount of DNA found in the various 200-ml supernatants divided by the total amount of DNA represented the total lysis of the K. pneumoniae population.
LD50 determinations and immunizations with ETC. The 50% lethal dose (LD50) value of each of the ETC preparations was determined by injecting the appropriate amount of ETC in 0.01 M Tris hydrochloride buffer (pH 8.0) intraperitoneally (i.p.) into Swiss-Webster mice (20 to 25 g). After 72 h of observation, dead mice were counted, and LD50 values were calculated by the method of Reed and Muench (21) . Before injection, the various ETC preparations were sterilized by exposure to UV irradiation (100 p.W/cm2 at room temperature for 30 min). The final ETC preparation was streaked on Trypticase soy agar for confirmation of sterility.
For all animal immunizations, the appropriate extracellular K. pneumoniae product (either ETC or LPS) was injected i.p. into Swiss-Webster mice in 0.01 M Tris hydrochloride buffer (pH 8.0). The animals were then rested for 14 days before challenge with the appropriate organism or extracellular product. When the immunized animals were challenged with live bacteria, the organisms were grown to an OD550 of 0.1 (early log phase) in DW medium and diluted in sterile phosphate-buffered saline to the appropriate concentration. Volumes of 1 ml were always injected. In experiments in which the immunized mice were challenged with purified bacterial product, the following protocol was employed. The material was always dialyzed against 0.01 M Tris hydrochloride buffer (pH 8.0). Before i.p. injection of this material into mice, it was sterilized by exposure to UV irradiation (100 p.W/cm2) at room temperature for 30 min. The final ETC preparation was streaked on Trypticase soy agar to confirm sterility.
RESULTS
Production of ETC by various strains of K. pneumoniae. Ability of ETC to provide protection against i.p. challenge with homologous and heterologous strains of K. pneumoniae. When mice were immunized with KP2 2-70 ETC, they were protected against a large challenge of the homologous organism (Table 2) . To see whether immunization with the ETC protected against a heterologous strain with a different type-specific capsule, I performed the following experiment. Twenty mice were immunized i.p. with sublethal amounts of KP2 2-70 ETC and later challenged with 180 CFU of KP1-LC. As can be seen in Table 2 , 80% of these animals survived the heterologous bacterial challenge, but 95% of control mice which received the same inoculum died as a result of their infection. This difference was shown to be statistically significant at the P < 0.005 level.
Ability of antibodies to ETC to neutralize ETC toxicity in vivo and passively protect against homologous K. pneumoniae challenge. Ten mice were injected i.p. with 150 ,ug of KP2 2-70 ETC. After 14 days, they were sacrificed by exsanguination, and the resulting serum constituted the immune mouse serum (IMS). Ten control mice were also exsanguinated to obtain normal mouse serum (NMS). A 2.5-mg sample of KP2 2-70 ETC was incubated for 30 min at room temperature with 0.5 ml of IMS, and a comparable amount of ETC was incubated under similar conditions with 0.5 ml of NMS. Then 500 ,ug of each ETC preparation was injected i.p. into 10 mice. Antibody to the ETC can neutralize its toxicity in vivo since antibody to the ETC protected 80% of the experimental animals from death, while 100% of animals that received ETC plus NMS died (Table 3) . This difference was shown to be statistically significant at the P < 0.005 level.
In addition, I sought to determine whether antibodies to the ETC would protect experimental animals against infection with homologous K. pneumoniae. Five mice were injected with sublethal concentrations of KP2 2-70 ETC (150 jig). After 14 days, these animals were sacrificed by exsanguination. In addition, serum was taken from five control mice. Then five mice each received 0.1 ml of IMS intravenously (i.v.), while five additional mice each received 0.1 ml of NMS. i.v. All these animals then received 160 CFU of KP2 2-70 i.p. Five mice also received i.p. 160 CFU of KP2 2-70 that had been incubated for 30 min at room temperature in 0.5 ml of IMS, while five additional mice received i.p. 160 CFU of KP2 2-70 that had been incubated for 30 min at room temperature. The results of these studies can also be seen in Table 3 . This table clearly shows that antibody to the ETC can passively protect mice against homologous challenge, whether the challenge organisms are delivered in combination with the antibody or separately after passive immunization of the animals with the antibody.
Ability of antibody to purified LPS to protect experimental animals against lethal K. pneumoniae challenge. Ten mice were injected i.p. with 100 jig of purified LPS. None of these animals died as a result of this injection. After 14 days, all 10 mice were sacrificed by exsanguination, and their sera were obtained. Six mice received 160 CFU of KP2 2-70 i.p. along with 0.1 ml of NMS i.v. Six mice received 160 CFU of KP2 2-70 i.p. along with 0.1 ml of mouse anti-LPS serum i.v. The results showed that antibody to the LPS protected approximately 67% (four of six survived) of the animals against a lethal KP2 2-70 challenge. All (100%) of the control animals which received 160 CFU of KP2 2-70 succumbed to their infection (data not shown). This difference was found to be statistically significant with a P value of <0.025.
Production of ETC at various points in the growth curve of KP2 2-70. Table 4 shows the production of certain extracellular materials by during different phases of the growth curve. This table shows that there is constant in vitro release, by the entire population, of the materials that form the ETC (LPS, CPS, and protein). A determination of the total DNA (cell pellet plus cell supernatant) and the DNA found in the supernatant allowed for an examination of the relationship between cell lysis and the extracellular release of the materials found in the ETC. The only detectable cell lysis (9.9%) occurred in the late stationary phase. 
DISCUSSION
We have recently described the production of an ETC by a strain of K. pneumoniae which appeared to be responsible for the lethality and extensive pulmonary tissue necrosis associated with pneumonia produced by this organism in an animal model (27) . In this paper, I show that two serotype 1 isolates and a capsular variant of one of these and two serotype 2 isolates and a capsular varient of one of these also produce this ETC ( Table 1 ). The K. pneumoniae serotype 1 strains appear to produce a great deal more ETC in vitro than do the K. pneumoniae serotype 2 strains (four-to fivefold), but the significance of this is unclear, as the LD50 values of the two groups (serotypes 1 and 2) of organisms are quite similar. In addition, isogenic strains have not yet been examined, and no correlation between virulence and the toxicity of the ETC can be inferred from the data of either of the K. pneumoniae serotypes examined.
Immunization with the ETC of KP2 2-70 induced protection in mice against homologous KP2 2-70 organisms (Table   2 ). This was not surprising in light of the studies which have shown that purified CPS of K. pneumoniae can elicit the production of protective antibody (3, 14, 24) . What was surprising was the finding that immunization with the KP2 2-70 ETC would protect experimental animals against a heterologous organism (Table 2) . Protection produced by Klebsiella capsular vaccines has, for the most part, been thought to be type specific (2), although Roe and Jones (14, 24) have reported heterologous protection using Klebsiella CPS vaccines. Because all the K. pneumoniae strains that I utilized in this study possessed the serotype 1 0 antigen, it is most probable that the protective antibody was directed against the 0 (LPS) antigen.
The induced protection appears to be antibody mediated since antibody to the ETC passively protected experimental animals against homologous ETC and homologous K. pneumoniae (Table 3) . Although it seems fairly well established that immunization of experimental animals with Klebsiella CPS can induce protection against homologous and heterologous K. pneumoniae (2, 3, 14, 24) (28) examined the role of the 0 and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. They demonstrated that both the K and 0 antigens of K. aerogenes were necessary to protect the organism from either complementmediated serum killing or phagocytosis in the absence of specific antiserum. In addition, they showed that optimal phagocytic ingestion of a K. aerogenes strain could be achieved in the presence of either anti-K or anti-O serum.
The components that form the ETC (LPS, CPS, and protein) appear to be released by K. pneumoniae KP2 2-70 during all phases of growth (Table 4 ). This table demonstrates that the ETC is probably released as a natural product of cell growth and not due to cell lysis. This is not surprising because as the members of the family Enterobacteriaceae grow in vitro, they shed outer membrane LPS into liquid media (17) . These LPS molecules are usually physically associated with bacterial outer membranes and phospholipids (9, 25) , and it is thought that they are shed into the media in fragments of bacterial outer membranes (26) . We have previously shown that these LPS-containing complexes are produced in vivo by at least one strain of K. pneumoniae (27) .
In conclusion, we envision the normal course of an infection by K. pneumoniae as follows. When K. pneumoniae is introduced into either the lungs or peritoneal cavity of an experimental animal, it is essentially the size of the cell-associated capsule (5) and the immunological status (2) of the animal that determines the outcome of the challenge. Once the infection has been established, it appears that the release of ELPS enhances the virulence of the invading organisms by producing a transient depression of the reticuloendothelial system, thus allowing for unrestrained growth of the organism in the early stages of the infection (4). Finally, when the invading bacterium has reached sufficiently high levels to produce enough ETC to cause lethality, the animal dies (27) . All strains of K. pneumoniae that I have examined to date are capable of producing the ETC, but if they do not possess sufficient cell-associated capsule, they are cleared by the phagocytic mechanisms of the animal and never get the opportunity to release extracellular toxic products. 
